Cargando…

Identifying familial hypercholesterolemia in an early onset ischemic cerebrovascular disease patient and the cascade screening in the pedigree: a case report

Familial hypercholesterolemia (FH) is one of the most common inherited metabolic disorders characterized by elevated low-density lipid cholesterol (LDL-C) levels that lead to coronary artery disease at an early age and a low occurrence of cerebrovascular disease. Low-density lipoprotein receptor (LD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Yuan, Zhao, Xiaoyan, Teng, Xiangyun, Zhang, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867922/ https://www.ncbi.nlm.nih.gov/pubmed/33569482 http://dx.doi.org/10.21037/atm-20-5600

Ejemplares similares

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
por: van El, Carla G., et al.
Publicado: (2018)

Long‐Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening
por: Kjærgaard, Kasper Aalbæk, et al.
Publicado: (2017)

Genetic variations in familial hypercholesterolemia and cascade screening in East Asians
por: Chan, Melody Lok‐Yi, et al.
Publicado: (2018)

CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design
por: Vaseghi, Golnaz, et al.
Publicado: (2019)

Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia
por: Silva, Pãmela Rodrigues de Souza, et al.
Publicado: (2018)

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia
por: Izar, Maria Cristina de Oliveira, et al.
Publicado: (2018)

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
por: Peterson, Amy L., et al.
Publicado: (2021)

Cascade Screening in Familial Hypercholesterolemia: Achieving Buy-In and Turning Patients Into Partners
por: Khoury, Michael
Publicado: (2023)

Premature Coronary Artery Disease and Familial Hypercholesterolemia: Need for Early Diagnosis and Cascade Screening in the Indian Population
por: Setia, N., et al.
Publicado: (2012)

Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report
por: Blokhina, Anastasia V., et al.
Publicado: (2022)

Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population
por: Jelassi, Awatef, et al.
Publicado: (2013)

Genetic Spectrum and Cascade Screening of Familial Hypercholesterolemia in Routine Clinical Setting in Hong Kong
por: Yip, Man-Kwan, et al.
Publicado: (2023)

Genetic analysis and management of a familial hypercholesterolemia pedigree with polygenic variants: Case report
por: Han, Yu, et al.
Publicado: (2023)

Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia
por: Alver, Maris, et al.
Publicado: (2018)

A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model
por: McGowan, Mary P., et al.
Publicado: (2021)

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2021)

Successful Treatment of Homozygous Familial Hypercholesterolemia Using Cascade Filtration Plasmapheresis
por: Kardaş1, Fatih, et al.
Publicado: (2012)

Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
por: Kullo, Iftikhar J., et al.
Publicado: (2018)

Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Characterization of familial hypercholesterolemia in Taiwanese ischemic stroke patients
por: Tung, Hsin, et al.
Publicado: (2021)

Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China
por: Jin, Weirong, et al.
Publicado: (2019)

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease
por: Cao, Ye-Xuan, et al.
Publicado: (2018)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Finding Importance for Universal Screening of Familial Hypercholesterolemia
por: Yokoyama, Shinji
Publicado: (2022)

Carotid Atherosclerosis in Ischemic Cerebrovascular Patients
por: Zhang, Ai Juan, et al.
Publicado: (2009)

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
por: Cuchel, Marina, et al.
Publicado: (2023)

Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation
por: Bangash, Hana, et al.
Publicado: (2022)

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
por: Jones, Laney K., et al.
Publicado: (2023)

Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
por: Jackson, Candace L., et al.
Publicado: (2021)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
por: Loh, Wann Jia, et al.
Publicado: (2022)

Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
por: Campbell-Salome, Gemme, et al.
Publicado: (2022)

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2023)

Correction to: Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights from the CASCADE FH Registry
Publicado: (2023)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, Japan
por: Matsunaga, Keiji, et al.
Publicado: (2022)

Novel compound heterozygous mutations in the PARK2 gene identified in a Chinese pedigree with early‐onset Parkinson's disease
por: Shi, Yingying, et al.
Publicado: (2017)

Identifying prenuptial births from family pedigrees using record linkage.
por: Kirelle, Nishadi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5f1pfbil3al6jnadp8cnhani8e